|
FY2026
12 months to Feb 28, 2026
|
FY2025
12 months to Feb 28, 2025
|
FY2024
12 months to Feb 29, 2024
|
FY2023
12 months to Feb 28, 2023
|
|
|---|---|---|---|---|
| Revenue | ||||
| Cost of goods sold | ||||
| Gross profit | ||||
| Operating expenses | ||||
| Selling expenses | ||||
| Depreciation and amortization expense | ||||
| General and administrative expenses | ||||
| Research and development expenses | ||||
| Total operating expenses | ||||
| Income from operations | ||||
| Non operating income and expenses | ||||
| Interest income | ||||
| Interest expense | ||||
| Other income/(expenses) | ||||
| Impairment of note receivable | ||||
| Total non-operating income and expenses | ||||
| Income/(loss) before income taxes | ||||
| Current income taxes | ||||
| Deferred income taxes | ||||
| Net income | ||||
| Net earnings/ (loss) per share, basic and diluted: | ||||
| Weighted average shares used in computing net loss per share, basic and diluted | ||||
| Foreign currency translation gain/(loss) | ||||
| Comprehensive income/(loss) | ||||
Loading...